CHMFL-ABL-121 is a highly potent inhibitor of type II ABL kinase (IC50s: 2 nM and 0.2 nM against purified inactive ABL wt and T315I kinase protein).

98%

Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution.

DMSO:55 mg/mL (94.72 mM)

ABL wt:2 nM, ABL-T315I:0.2 nM

CHMFL-ABL-121 induces apoptosis and arrests the cell cycle at the G0/G1 phase. CHMFL-ABL-121 dose-dependently inhibits BCRABL’s auto-phosphorylation at the Y245 site in MEG-01 (EC50<10 nM), K562 (EC50<10 nM), and KU812 (EC50<30 nM) cells and also significantly blocks the phosphorylation of downstream signaling mediators STAT5, CrkL, and ErK[1].